Recent research further supports BMT as the preferable treatment for CGD

Two recent, independent studies in the UK and Sweden have underlined the benefits of treating children with CGD by bone marrow transplant (BMT). The studies compared outcomes between patients using BMT and conventional treatments such as antifungal and antibacterial prophylaxis.

The Swedish study showed over 90% of patients who had BMT were alive and well compared to poor outcomes as a result of life-threatening infections and complications in patients treated conventionally.

The collaborative work between the Great North Children’s Hospital, Newcastle and Great Ormond Street Hospital, London, headed by Dr Andrew Gennery, also found children with CGD not undergoing transplantation have more serious infections, episodes of surgery, and admissions compared with children after BMT.

‘The results of these studies validate further the medical advice to treat CGD as early as possible by BMT’, said Dr Gennery.'